You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

inotuzumab ozogamicin

Showing 51 - 75 of 117
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukaemia Trial in Worldwide (Gemtuzumab ozogamicin, Liposomal daunorubicin, Mitoxantrone)

Recruiting
  • Acute Myeloid Leukaemia
  • Gemtuzumab ozogamicin
  • +6 more
  • Adelaide, Australia
  • +67 more
Sep 30, 2021

Lymphoma, Non-Hodgkin Trial in Worldwide (Inotuzumab ozogamicin, Rituximab, rituximab + gemcitabine)

Terminated
Has Results
  • Lymphoma, Non-Hodgkin
  • Inotuzumab ozogamicin
  • +3 more
  • Burbank, California
  • +176 more
Dec 19, 2018

Acute Myeloid Leukemia Trial in Austria, Germany (Gemtuzumab Ozogamicin (Mylotarg), standard chemo)

Completed
  • Acute Myeloid Leukemia
  • Gemtuzumab Ozogamicin (Mylotarg)
  • standard chemotherapy
  • Graz, Austria
  • +59 more
Sep 28, 2021

Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blasts 10 Percent or More of Bone Marrow

Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 31, 2022

Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Juvenile Myelomonocytic Leukemia Trial in New York (Fludarabine, Busulfan,

Completed
  • Acute Myelogenous Leukemia
  • +2 more
  • New York, New York
    Columbia University Medical Center
Aug 4, 2021

Acute Myeloid Leukemia Trial in Heidelberg (Gemtuzumab Ozogamicin 147, Gemtuzumab Ozogamicin 1, Glasdegib)

Terminated
  • Acute Myeloid Leukemia
  • Gemtuzumab Ozogamicin 147
  • +3 more
  • Heidelberg, Baden-Württemberg, Germany
    University Hospital Heidelberg, Internal Medicine V
Jun 27, 2022

Acute Myeloid Leukemia Trial in Germany (MODULE: conventional chemo (Cytarabine+Daunorubicin) in combination with

Active, not recruiting
  • Acute Myeloid Leukemia
  • MODULE: conventional chemotherapy (Cytarabine+Daunorubicin) in combination with midostaurin+GO
  • +4 more
  • München, Bayern, Germany
  • +10 more
Aug 31, 2021

ECG, Pharmacokinetics, Safety Trial in Worldwide (Gemtuzumab Ozogamicin)

Completed
Has Results
  • ECG
  • +2 more
  • Gemtuzumab Ozogamicin
  • Augusta, Georgia
  • +23 more
Feb 28, 2022

Lymphoma, Follicular Trial in Worldwide (inotuzumab ozogamicin, rituximab, cyclophosphamide)

Terminated
Has Results
  • Lymphoma, Follicular
  • inotuzumab ozogamicin
  • +7 more
  • Mission Hills, California
  • +38 more
Dec 8, 2017

Leukemia, Myeloid, Acute Trial in Jerusalem (Vyxeos, Mylotarg)

Recruiting
  • Leukemia, Myeloid, Acute
  • Jerusalem, Yerushalayim, Israel
    Shaare Zedek Medical Center
Oct 25, 2022

Lymphoma Trial in Worldwide (Inotuzumab Ozogamicin (CMC-544))

Completed
Has Results
  • Lymphoma
  • Inotuzumab Ozogamicin (CMC-544)
  • Birmingham, Alabama
  • +41 more
Oct 27, 2017

Lymphoma, B-Cell Trial in Worldwide (inotuzumab ozogamicin (CMC-544), rituximab)

Completed
Has Results
  • Lymphoma, B-Cell
  • Maywood, Illinois
  • +35 more
Oct 30, 2017

Acute Lymphoblastic Leukemia Trial in Houston (CMC-544 (Inotuzumab Ozogamycin), Rituximab)

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 21, 2019

Leukemia Trial in Israel, United States (biological, drug, procedure)

Completed
Has Results
  • Leukemia
  • sargramostim
  • +7 more
  • Birmingham, Alabama
  • +98 more
Oct 23, 2020

Acute Lymphoblastic Leukemia Treated With Anti-CD22

Recruiting
  • Acute Lymphoblastic Leukemia
  • Anti-CD22 Immunotoxin
  • Meldola (FC), FC, Italy
  • +4 more
Feb 25, 2021

Acute Myeloid Leukemia Trial in Pittsburgh (mitoxantrone + etoposide + gemtuzumab ozogamicin)

Recruiting
  • Acute Myeloid Leukemia
  • mitoxantrone + etoposide + gemtuzumab ozogamicin
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Feb 9, 2022

Acute Myeloid Leukemia Trial in New York (CPX-351, Gemtuzumab Ozogamicin)

Recruiting
  • Acute Myeloid Leukemia
  • New York, New York
    Weill Cornell Medical College
Dec 21, 2021

Acute Myeloid Leukemia Trial in Canada, Puerto Rico, United States (procedure, drug, behavioral)

Recruiting
  • Acute Myeloid Leukemia
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +13 more
  • Birmingham, Alabama
  • +187 more
Apr 28, 2022

Acute Lymphocytic Leukemia Trial in United States (Inotuzumab Ozogamicin)

Completed
Has Results
  • Acute Lymphocytic Leukemia
  • Inotuzumab Ozogamicin
  • Duarte, California
  • +14 more
Mar 2, 2017

Novo Acute Myeloid Leukemia Trial in Spain (Mylotarg)

Completed
Has Results
  • Novo Acute Myeloid Leukemia
  • Badalona, Barcelona, Spain
  • +5 more
Jan 26, 2021

Acute Myeloid Leukemia Trial in Heidelberg (Bortezomib, Gemtuzumab Ozogamicin)

Recruiting
  • Acute Myeloid Leukemia
  • Heidelberg, Baden-Württemberg, Germany
    University Hospital Heidelberg, Internal Medicine V
May 25, 2020

B-cell Lymphoma Refractory Trial in Bellinzona, Bern, San Gallen (Inotuzumab Ozogamicin, Temsirolimus)

Completed
  • B-cell Lymphoma Refractory
  • Bellinzona, Ticino, Switzerland
  • +2 more
Jun 6, 2016

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Completed
Has Results
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +13 more
  • Stanford, California
  • +3 more
May 2, 2019

Acute Myeloid Leukaemia, Myelodysplastic Syndrome Trial in Denmark, United Kingdom (Arm A Mylotarg plus DA Versus CPX-351, Arm B

Unknown status
  • Acute Myeloid Leukaemia
  • Myelodysplastic Syndrome
  • Arm A Mylotarg plus DA Versus CPX-351
  • +5 more
  • Aalborg, Denmark
  • +86 more
Jan 22, 2020

Acute Myeloid Leukemia Trial in La Jolla, Stanford, Atlanta (5-Azacitidine, Gemtuzumab ozogamicin)

Completed
Has Results
  • Acute Myeloid Leukemia
  • La Jolla, California
  • +2 more
Jan 31, 2019